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Background
Type 1 diabetes mellitus (T1D) accounts for ~10% of all
diabetes cases, and it is caused by autoimmune destruc-
tion of pancreatic beta-cells, which leads to insulin defi-
ciency and fates individuals to require insulin treatment
to survive. The triggering of autoimmunity against beta-
cells is caused by interaction between environmental
and genetic risk factors. Among the several loci asso-
ciated with T1D, the human leukocyte antigen (HLA)
class II DR/DQ locus is the main genetic risk factor for
T1D, accounting for 30-50% of genetic risk for this dis-
ease. Other genes have been associated with minor
effects on T1D risk when compared with HLA, with dif-
ferent studies indicating that the effect of non-HLA
polymorphisms on predisposition for T1D may be dif-
ferent according to HLA DR/DQ types. In this scenario,
a recent study identified a minimum set of three poly-
morphisms (rs3104413, rs2854275, rs9273363) which
can predict high-risk HLA-DR/DQ types relevant to
T1D.
Objective
To evaluate frequencies of high-risk T1D HLA-DR/DQ
haplotypes in a Southern Brazilian population using a
minimum set of HLA polymorphisms (rs3104413C/G,
rs2854275A/C and rs9273363A/C).
Materials and methods
We analyzed 387 T1D patients (cases) and 375 healthy
blood-donor subjects (controls). The local ethics com-
mittee approved the protocol, and all patients signed an
informed consent form. Polymorphisms of interest were
genotyped by allelic discrimination – RT-PCR technique
using TaqMan MGB probes (Life Technologies). Haplo-
type combinations of the three analyzed polymorphisms
were used for defining the HLA types relevant to T1D
(Nguyen et al*), distinguishing the highest-risk DR4-
DQ8 and DR3/4-DQ types.
Results
Minor alleles frequencies of rs3104413, rs2854275,
rs9273363 were increased in T1D patients as compared
to non-diabetic subjects (rs3104413C: 44.4% vs. 11.2%;
rs2854275A: 12.9% vs. 1.9%; rs9273363A: 43.9% vs. 9.9%;
all P <0.0001).The frequency of high-risk DR4-DQ8 type
was 66.7% in T1D cases and 15.3% in controls
(OR=11.059, 95%CI 6.68-18.29; P <0.0001).The high-risk
DR3/4-DQ8 heterozygous haplotype was observed in
only one T1D patients and in none control subject.
Conclusion
As expected, the high-risk HLA-DR4/DQ8 haplotype is
associated with increased risk for T1D in our population.
The genetic risk of non-HLA genes on T1D in Southern
Brazil can now be correct for different high-risk HLA-DR/
DQ types.
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